Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Completion Of A Urological Timeline

Research Leaders

6 sponsors active, led by Gadjah Mada University

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Completion Of A Urological Timeline1
  • Semistructured Indepth Interviews With Standardized Validated Questionnaires1
  • Cancer Patient Navigation Services1

Active Sponsors

  • Gadjah Mada University1
  • Indonesia Endowment Fund For Education Lpdp Ministry Of Finance Republik Of Indonesia1
  • University Hospital Ghent1
  • University Ghent1
  • Assistance Publique Hôpitaux De Paris1

Related Conditions

  • Adverse Childhood Experiences1
  • Genitourinary Issues1
  • Newly Diagnosed Breast Cancer1
  • Breast Cancer And Rehabilitation1
  • Quality Of Life1

Activity Timeline